ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 132 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,779,422 | -24.6% | 537,359 | +6.0% | 0.13% | -34.0% |
| Q2 2023 | $14,303,034 | +112.9% | 507,020 | +29.8% | 0.19% | +105.4% |
| Q1 2023 | $6,718,010 | +257.5% | 390,582 | +859.3% | 0.09% | +304.3% |
| Q1 2022 | $1,879,000 | -33.1% | 40,714 | -37.1% | 0.02% | -28.1% |
| Q1 2021 | $2,808,000 | +367.2% | 64,718 | +459.4% | 0.03% | +540.0% |
| Q4 2020 | $601,000 | -5.2% | 11,570 | -40.4% | 0.01% | -61.5% |
| Q3 2020 | $634,000 | – | 19,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 2,099,583 | $42,117,635 | 14.06% |
| Mayo Clinic | 187,143 | $3,754,089 | 7.23% |
| Matrix Capital Management Company, LP | 13,959,973 | $280,037,058 | 3.36% |
| 5AM Venture Management, LLC | 490,000 | $9,829,400 | 2.83% |
| Eventide Asset Management | 7,814,039 | $156,749,622 | 2.82% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 961,486 | $19,287,410 | 2.70% |
| Avidity Partners Management LP | 2,100,000 | $42,126,000 | 1.70% |
| First Light Asset Management, LLC | 848,477 | $17,020,449 | 1.62% |
| Sofinnova Investments, Inc. | 1,211,641 | $24,305,518 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 386,525 | $7,753,692 | 1.51% |